Tango Therapeutics (TNGX) Change in Account Payables (2020 - 2026)

Tango Therapeutics' Change in Account Payables history runs 7 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• In Q1 2026, Change in Account Payables rose 9.51% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at -$670000.0 (down 12.42% YoY), while the FY2025 annual figure was -$825000.0, up 30.32% from the prior year.
• Change in Account Payables was $1.8 million for Q1 2026 at Tango Therapeutics, up from -$1.2 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $4.5 million in Q3 2022 to a low of -$2.8 million in Q2 2024.
• Historically, Change in Account Payables has averaged -$48941.2 across 5 years, with a median of -$359000.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Change in Account Payables surged 532.31% in 2023, then tumbled 2748.86% in 2024.
• A 5-year view of Change in Account Payables shows it stood at -$1.0 million in 2022, then surged by 91.54% to -$88000.0 in 2023, then sank by 2748.86% to -$2.5 million in 2024, then soared by 50.9% to -$1.2 million in 2025, then surged by 245.0% to $1.8 million in 2026.
• The last three Change in Account Payables figures came in at $1.8 million (Q1 2026), -$1.2 million (Q4 2025), and -$344000.0 (Q3 2025), per Business Quant data.